Responsibilities of JDC. The JDC shall have the following responsibilities and authority:
Responsibilities of JDC. (a) The JDC shall, unless otherwise agreed to by the Parties:
Responsibilities of JDC. 20 SECTION 4.03. Lead Development Party..................................... 21 SECTION 4.04.
Responsibilities of JDC. (a) The JDC shall oversee the Development of (i) Collaboration Products for Development Indications, and (ii) to the extent ORTHO exercises its option(s) under Section 5.04 to expand the Field to include Additional Indications, Collaboration Products for such Additional Indications, in order to obtain Regulatory Approvals in the Co-Promotion Territory as set forth in this Article IV. The JDC will also oversee the preparation of Development Plans and Development Budgets and submit them to the Steering Committee for review and as required, approval and will facilitate the flow of Information with respect to Development being conducted for each Collaboration Product for each Development Indication and Additional Indication, if any. In addition, as part of an approved Commercialization Budget and/or an approved Launch Budget, the JDC will provide such support with respect to Phase IIIB Clinical Trials and Phase IV Clinical Trials as may be reasonably requested by the JCC.
Responsibilities of JDC. Subject to Section 2.2.4, the Joint Development Committee shall perform the following functions:
Responsibilities of JDC. Subject to Section 3.07, the JDC shall perform the following functions:
Responsibilities of JDC. 9 SECTION 2.03. DEVELOPMENT.............................................. 10 SECTION 2.04. **....................................................... 11 SECTION 2.05. DRUG APPROVAL APPLICATIONS............................... 12 SECTION 2.06. COSTS OF DEVELOPMENT..................................... 13 SECTION 2.07.
Responsibilities of JDC. The JDC shall perform the following functions, some or all of which may be addressed directly at each meeting of the JDC:
Responsibilities of JDC. Subject to the limitations set forth in Section 3.6, the JDC shall perform the following functions: [* * *] The confidential content of this Exhibit 10.1 has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. CONFIDENTIAL TREATMENT REQUESTED BY ASSEMBLY BIOSCIENCES, INC.
Responsibilities of JDC. 9 SECTION 2.03. DEVELOPMENT. . . . . . . . . . . . . . . . . . . . . . . . . . 10 SECTION 2.04. ** . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 SECTION 2.05. DRUG APPROVAL APPLICATIONS . . . . . . . . . . . . . . . . . . 12 SECTION 2.06. COSTS OF DEVELOPMENT . . . . . . . . . . . . . . . . . . . . . 13 SECTION 2.07.
